Art. 7 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…

In forcecited 9×
1.

An application for marketing authorisation under Article 6 of Directive 2001/83/EC in respect of a medicinal product for human use which is not authorised in the Community at the time of entry into force of this Regulation shall be regarded as valid only if it includes, in addition to the particulars and documents referred to in Article 8(3) of Directive 2001/83/EC, one of the following:

(a)

the results of all studies performed and details of all information collected in compliance with an agreed paediatric investigation plan;

(b)

a decision of the Agency granting a product-specific waiver;

(c)

a decision of the Agency granting a class waiver pursuant to Article 11;

(d)

a decision of the Agency granting a deferral.

For the purposes of point (a), the decision of the Agency agreeing the paediatric investigation plan concerned shall also be included in the application.

2.

The documents submitted pursuant to paragraph 1 shall, cumulatively, cover all subsets of the paediatric population.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…57Law

    … лекарствени продукти; у) вземане на решения, както е посочено в член 7, параграф 1 от Регламент (ЕО) № 1901/2006 на Европейския парламент …

  • Regulation (EU) 2019/51Law

    … лекарствени продукти; у) вземане на решения, както е посочено в член 7, параграф 1 от Регламент (ЕО) № 1901/2006 на Европейския парламент …

  • Order of the President of the Court of First Instance of 24 April 2009. Nycomed Danmark ApS v Agence européenne des médicaments (EMEA).Decision

    24 Apr 2009 · 62009TO0052

  • Judgment of the General Court (Third Chamber) of 14 December 2011. Nycomed Danmark ApS v European Medicines Agency (EMA).Decision

    Articles 1, 2, 3, 6, 7, 11, 13, 15 and 16 of Regulation No 1901/2006 read as follows: ‘Article 1 This Regulation lays down rules concerning the development of medicinal products for human use in order to meet the specific therapeutic …

    14 Dec 2011 · 62009TJ0052

  • Judgment of the General Court (Fifth Chamber), 4 July 2013. Laboratoires CTRS v European Commission.Decision

    As regards the first argument, under Article 9 of Regulation No 1901/2006, Article 7 of that regulation is not to apply to products authorised under, inter alia, Article 10a of Directive 2001/83.

    4 Jul 2013 · 62012TJ0301

  • Opinion of Mr Advocate General Bot delivered on 9 June 2011. Merck Sharp & Dohme Corp. v Deutsches Patent- und Markenamt.Decision

    Significantly, in my opinion, an examination of the scheme of Regulation No 1768/92 and the Medicines Regulation shows that the duration of the SPC is not one of the conditions for granting the six-month extension established by the …

    9 Jun 2011 · 62010CC0125

  • Judgment of the General Court (Tenth Chamber, Extended Composition) of 13 November 2024. Orion Oyj v European Commission.Decision

    In 2008, while the clinical programme for Dexdor was ongoing, the applicant submitted an application for a paediatric investigation plan in accordance with Article 7 of Regulation (EC) No 1901/2006 of the European Parliament and of the …

    13 Nov 2024 · 62020TJ0223

  • Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018…1Law

    … procedures for medicinal products for human use and veterinary medicinal products; taking decisions as referred to in Article 7(1) of Regulation (EC) No 1901/2006 of the European Parliament and of the Council; ; the following point is …

  • Judgment of the Court (Second Chamber) of 21 June 2018. Pfizer Ireland Pharmaceuticals, Operations Support Group v Orifarm GmbH.Decision

    Article 36(1) of Regulation No 1901/2006 provides that, where an application under Article 7 or 8 of the regulation includes the results of all studies conducted in compliance with an agreed paediatric investigation plan, the holder of the …

    21 Jun 2018 · 62016CJ0681